Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11721
-
11722
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Published 2016“…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
-
11723
-
11724
-
11725
Changes in neuronal morphology after 150 nM sAPP-Fc added to 5DIV neurons.
Published 2011“…<p>Morphometric analysis 96 hours after the addition of 150 nM sAPP-Fc to 5DIV neurons shows that: (<b>A</b>) sAPP-Fc induces a significant decrease of primary dendrite number (control (Ctrl) vs sAPP-Fc: p<0.0276). …”
-
11726
-
11727
-
11728
Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC.
Published 2017“…Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”
-
11729
Activity of 7DW8-5 on DCs and <i>i</i>NKT cells in rhesus macaques.
Published 2013“…Each column indicates the mean value for 5 animals per group; errors bars denote SEM. * = p < 0.05 and ** = p <0.01 when compared to control group receiving AdPfCA + 0 µg 7DW8-5. …”
-
11730
Anatomical confirmation of drug injection sites.
Published 2015“…Limb withdrawal threshold is presented as mean + SEM. (**<i>P</i><0.01, t-test for paired data). gf—gram force.…”
-
11731
Diannexin (DA5) reduces leukocyte influx 3 days after I/R.
Published 2011“…(C) When compared to vehicle-treated mice, leukocyte influx in renal tissue of DA5-treated mice was decreased on day 3 after IRI induction. …”
-
11732
Intra- & Inter-assay Variance for the flow cytometric analysis of STAT5Ptyr in human peripheral blood monocytes.
Published 2013“…However, this significant difference decreased to 5.4-fold at 48 hr (*p = 0.013), due to the increased inter-assay variability seen in control samples after storage.…”
-
11733
-
11734
-
11735
-
11736
-
11737
Both WD and AD shift OD in the binocular V1 in fully adult mice.
Published 2019“…<p>(<b>a, b</b>) V1 activity evoked by visual stimulation of the contra or ipsilateral eye in untreated control mice (n = 5) remained unchanged at 0, 3 and 7 days. …”
-
11738
-
11739
Attenuation of CDK expression and cyclin D-CDK4/6 activity by androgen in PC3-Lenti-AR.
Published 2015“…(E) In comparison to control samples, DHT treatment for 24 hours significantly decreased CDK4 and CDK6 mRNAs and pre-mRNAs 1.5 fold or more and increased CDKN1A mRNA and pre-mRNA 2 fold or more, suggesting AR-mediated regulation of transcription at these genes, n = 3. …”
-
11740